Education
About Us
Working with TipRanks
Follow Us
ZimVie Inc (ZIMV)
NASDAQ:ZIMV
ZIMV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.55 - $22.40
Previous CloseN/A
Volume26.95K
Average Volume (3M)147.55K
Market Cap
$244.31M
Enterprise Value$401.54M
Total Cash (Recent Filing)$74.97M
Total Debt (Recent Filing)$232.57M
Price to Earnings (P/E)―
Beta1.28
Next Earnings
Jul 31, 2025EPS Estimate
0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.27
Shares Outstanding27,921,549
10 Day Avg. Volume189,780
30 Day Avg. Volume147,554
Financial Highlights & Ratios
PEG Ratio-0.10
Price to Book (P/B)0.63
Price to Sales (P/S)0.00
P/FCF Ratio32.56
Enterprise Value/Market Cap1.64
Enterprise Value/Revenue0.19
Enterprise Value/Gross Profit1.49
Enterprise Value/Ebitda2.19
Forecast
1Y Price Target
$11.67Price Target Upside31.42% Upside
Rating ConsensusHold
Number of Analyst Covering4
ZimVie Inc News
PremiumCompany Announcements
ZimVie Inc Holds Annual Shareholders MeetingPremiumCompany Announcements
Zimvie Inc. Earnings Call: Profitability Gains Amid Revenue Challenges
PremiumCompany Announcements
ZimVie Inc. Reports Q1 2025 Financial Results
PremiumCompany Announcements
ZimVie Inc Reports Q1 2025 Financial ResultsBulls Say, Bears Say
Bulls Say
Market StabilityThe overall health of the dental market was discussed, indicating stability and potential growth opportunities for Zimvie Inc.
ProfitabilityProfitability was strong and ZIMV is able to absorb a modest impact from tariffs.
Revenue GrowthIn early April, ZIMV acquired a distributor in Costa Rica for $3.3M which should be accretive to revenue and margins.
Bears Say
Cost StructureTariffs were mentioned as a factor that could impact the company's cost structure.
Product PerformanceImplants and scanners were the two weakest product groups in the quarter.
Revenue PerformanceZIMV missed consensus revenue while adjusted EBITDA beat expectations in 1Q25.
Ownership Overview
21.86% Insiders
20.27% Mutual Funds
31.32% Other Institutional Investors
11.32% Public Companies and
Individual Investors
ZIMV FAQ
What was ZimVie Inc’s price range in the past 12 months?
ZimVie Inc lowest stock price was $8.54 and its highest was $22.40 in the past 12 months.
What is ZimVie Inc’s market cap?
ZimVie Inc’s market cap is $244.31M.
When is ZimVie Inc’s upcoming earnings report date?
ZimVie Inc’s upcoming earnings report date is Jul 31, 2025 which is in 70 days.
How were ZimVie Inc’s earnings last quarter?
ZimVie Inc released its earnings results on May 08, 2025. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.209 by $0.061.
Is ZimVie Inc overvalued?
According to Wall Street analysts ZimVie Inc’s price is currently Undervalued.
Does ZimVie Inc pay dividends?
ZimVie Inc does not currently pay dividends.
What is ZimVie Inc’s EPS estimate?
ZimVie Inc’s EPS estimate is 0.23.
How many shares outstanding does ZimVie Inc have?
ZimVie Inc has 27,921,549 shares outstanding.
What happened to ZimVie Inc’s price movement after its last earnings report?
ZimVie Inc reported an EPS of $0.27 in its last earnings report, beating expectations of $0.209. Following the earnings report the stock price went down -4.679%.
Which hedge fund is a major shareholder of ZimVie Inc?
Currently, no hedge funds are holding shares in ZIMV
ZimVie Inc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$11.67 (31.42% Upside)
$11.67 (31.42% Upside)
Blogger Sentiment
Bullish
ZIMV Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 149.5K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.85%
12-Months-Change
Fundamentals
Return on Equity
-6.35%
Trailing 12-Months
Asset Growth
-36.35%
Trailing 12-Months
Company Description
ZimVie Inc
ZimVie Inc (ZIMV) is a global medical technology company that operates primarily in the healthcare sector. The company specializes in the development, manufacturing, and marketing of a wide range of medical devices and solutions. ZimVie focuses on providing innovative products and services to improve patient care in areas such as dental and spine health. The company's offerings include dental implants, surgical instruments, and spinal solutions, aimed at enhancing clinical outcomes and patient experience.
ZIMV Company Deck
ZIMV Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a strong focus on improving profitability and cost management, with significant achievements in EBITDA margin growth and strategic acquisitions. However, challenges such as declining revenue, particularly in implant sales and international markets, as well as the impact of tariffs, present ongoing concerns.Read More>ZIMV Stock 12 Month Forecast
Average Price Target
$11.67
▲( 31.42% Upside)